2018
DOI: 10.1007/s11657-018-0540-7
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern Mediterranean Region: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
39
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 47 publications
(48 citation statements)
references
References 29 publications
1
39
0
3
Order By: Relevance
“…However, such heterogeneity is usually seen in the epidemiological studies and is not unexpected. (18,43)…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, such heterogeneity is usually seen in the epidemiological studies and is not unexpected. (18,43)…”
Section: Discussionmentioning
confidence: 99%
“…(16) Another survey from Iran reported a death rate of 11.2% during 2007-2008. (17) Our recent metaanalysis showed that the prevalence of osteoporosis has increased over the last years in the EMR (18) therefore, osteoporotic fractures will probably become more prevalent and become an even greater concern for this region.…”
mentioning
confidence: 99%
“…Osteoporosis (OP) is a common bone disease characterized by decreased bone density, increased bone fragility, and increased risk of fracture [1]. According to the World Health Organization report, with the global population aging, approximately 72% of women and 62% of men over 50 years old are estimated to suffer from OP or osteopenia by 2022 [2]. OP has a high incidence of fractures and mortality rates and has become a global epidemic [3].…”
Section: Introductionmentioning
confidence: 99%
“…RAW264.7 cells are a well-established preosteoclast cell line. After treatment with specific growth factors, such as RANKL, RAW264.7 cells can be differentiated into osteoclasts [2]. Therefore, RANKL-induced RAW264.7 cells may be used for the study of osteoclasto genesis in vitro.…”
Section: Introductionmentioning
confidence: 99%
“…Considering the great inuence and serious consequences of osteoporosis, this disease is classied by the World Health Organization (WHO) as a major public health concern. [4][5][6] To restore proper bone structure and treat osteoporosis, it is important to re-establish the balance between bone resorption and bone formation. Numerous studies have investigated this issue, and many therapeutic agents have been proposed, including antiresorptives such as bisphosphonates, selective estrogen receptor modulator (SERM), and salmon calcitonin.…”
Section: Introductionmentioning
confidence: 99%